Product pipeline
PRODUCT
INDICATION
RESEARCH
PRECLINICAL
PHASE I
PHASE II
PHASE III
ATL1103
Acromegaly
ATL1102
Multiple Sclerosis
ATL1102
DMD

What we're working on.
ATL1102
DMD is caused by a mutation in the muscle dystrophin gene leading to severe progressive muscle loss and premature death.
ATL1102
A disease in which the immune system eats away at the protective covering of nerves.
ATL1103
A disorder in adults in which the pituitary gland produces too much growth hormone.
Other indications
Limb-Girdle Muscular Dystrophy
A diseases that cause weakness and wasting of the muscles in the arms and legs.
Long Covid
A variety of new, returning or ongoing symptoms that people experience more than four weeks after getting COVID-19.
The people driving Antisense.
Our Antisense directors are committed staff members and are ready to help.
